Entera Bio Ltd. (ENTX) DCF Valuation

Entera Bio Ltd. (ENTX) DCF Valuation
  • ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
  • ✓ Design Profissional: Modelos Confiáveis ​​E Padrão Da Indústria
  • ✓ Pré-Construídos Para Uso Rápido E Eficiente
  • ✓ Não É Necessária Experiência; Fácil De Seguir

Entera Bio Ltd. (ENTX) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Enhance your investment strategies with the Entera Bio Ltd. (ENTX) DCF Calculator! Explore real financial data for Entera Bio, adjust growth projections and expenses, and observe how these adjustments affect the intrinsic value of Entera Bio Ltd. (ENTX) in real-time.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .2 .4 .6 .1 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 54.66 56.44 -76.53 -100 -16.36 -16.36 -16.36 -16.36 -16.36
EBITDA -11.3 -11.1 -12.2 -12.9 -8.8 .0 .0 .0 .0 .0
EBITDA, % -4807.63 -3042.47 -2130.3 -9604.48 100 -60 -60 -60 -60 -60
Depreciation .2 .1 .1 .1 .1 .0 .0 .0 .0 .0
Depreciation, % 100.85 17.26 9.28 47.76 100 54.86 54.86 54.86 54.86 54.86
EBIT -11.6 -11.2 -12.2 -12.9 -8.9 .0 .0 .0 .0 .0
EBIT, % -4908.47 -3059.73 -2139.58 -9652.24 100 -60 -60 -60 -60 -60
Total Cash 15.2 8.6 24.9 12.3 11.0 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .3 .3 .2 .2 .0
Account Receivables, % 117.8 69.86 32.05 183.58 100
Inventories .1 -.1 .0 -.3 .0 .0 .0 .0 .0 .0
Inventories, % 32.2 -25.48 0 -219.4 100 1.34 1.34 1.34 1.34 1.34
Accounts Payable .3 .2 .2 .0 .1 .0 .0 .0 .0 .0
Accounts Payable, % 141.53 44.93 29.07 12.69 100 57.34 57.34 57.34 57.34 57.34
Capital Expenditure .0 -.1 .0 .0 .0 .0 .0 .0 .0 .0
Capital Expenditure, % -16.95 -14.52 -2.98 -35.07 100 -13.9 -13.9 -13.9 -13.9 -13.9
Tax Rate, % -0.32731 -0.32731 -0.32731 -0.32731 -0.32731 -0.32731 -0.32731 -0.32731 -0.32731 -0.32731
EBITAT -11.7 -11.2 -12.2 -13.1 -8.9 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -11.5 -11.2 -12.1 -13.0 -8.8 -.1 .0 .0 .0 .0
WACC, % 11.91 11.91 11.91 11.91 11.91 11.91 11.91 11.91 11.91 11.91
PV UFCF
SUM PV UFCF -.1
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value 0
Net Debt -11
Equity Value 11
Diluted Shares Outstanding, MM 29
Equity Value Per Share 0.36

What You Will Receive

  • Comprehensive Financial Model: Entera Bio Ltd.’s (ENTX) actual data facilitates accurate DCF valuation.
  • Complete Forecast Control: Modify revenue growth, profit margins, WACC, and other essential factors.
  • Real-Time Calculations: Automatic updates provide immediate results as adjustments are made.
  • Professional-Grade Template: An optimized Excel file crafted for high-quality valuation.
  • Flexible and Reusable: Designed for adaptability, allowing for repeated use in detailed forecasting.

Key Features

  • Comprehensive Financial Data: Gain access to precise pre-loaded historical figures and future forecasts for Entera Bio Ltd. (ENTX).
  • Adjustable Forecast Parameters: Modify highlighted cells for key metrics such as WACC, growth rates, and profit margins.
  • Real-Time Calculations: Enjoy automatic updates for DCF, Net Present Value (NPV), and cash flow analyses.
  • User-Friendly Dashboard: Clear and informative charts and summaries to help you visualize your valuation outcomes.
  • Designed for All Users: An intuitive layout tailored for investors, CFOs, and consultants, whether experienced or new.

How It Works

  • Step 1: Download the prebuilt Excel template featuring Entera Bio Ltd.'s (ENTX) data.
  • Step 2: Review the pre-populated sheets to grasp the essential metrics.
  • Step 3: Modify forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
  • Step 4: Instantly see recalibrated results, including Entera Bio Ltd.'s (ENTX) intrinsic value.
  • Step 5: Make informed investment choices or create reports based on the results.

Why Choose Entera Bio Ltd. (ENTX)?

  • Innovative Solutions: Leverage cutting-edge technology for advanced drug delivery systems.
  • Proven Track Record: Backed by successful clinical trials and strong research foundations.
  • Customizable Approaches: Adapt our solutions to meet your specific therapeutic needs.
  • Clear Communication: Transparent reporting and insights for informed decision-making.
  • Endorsed by Professionals: Trusted by leading experts in the biopharmaceutical industry.

Who Should Use Entera Bio Ltd. (ENTX)?

  • Professional Investors: Develop comprehensive and accurate valuation models for investment assessments.
  • Corporate Finance Teams: Evaluate valuation scenarios to inform strategic decisions within the company.
  • Consultants and Advisors: Deliver precise valuation insights for Entera Bio Ltd. (ENTX) to clients.
  • Students and Educators: Utilize real-world data to enhance learning and practice in financial modeling.
  • Biotech Enthusiasts: Gain insights into how biotech firms like Entera Bio Ltd. (ENTX) are valued in the market.

What the Template Contains

  • Preloaded ENTX Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
  • DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
  • Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
  • Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
  • Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
  • Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.

No products were found matching.